PROVIDENCE, R.I. – Amgen will expand in Rhode Island, with a new $160-million, next-generation biomanufacturing plant that will be the first of its kind in the United States. The facility, which will produce approximately 150 new highly skilled manufacturing jobs, will be supported by incentives from Rhode Island’s innovative toolkit of economic development programs. “I am thrilled that Amgen is planning to expand and bring new, highly skilled jobs to Rhode Island and further enhance the State’s life sciences community and manufacturing expertise,” said Governor Gina M. Raimondo. “We welcome Amgen’s future health care advancements for patients around the world … Read more